307 related articles for article (PubMed ID: 17569671)
1. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-3F is an inhibitor of tumor angiogenesis.
Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
4. Expression of semaphorin 3A and neuropilin 1 in asthma.
Shim EJ; Chun E; Kang HR; Cho SH; Min KU; Park HW
J Korean Med Sci; 2013 Oct; 28(10):1435-42. PubMed ID: 24133346
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
Haixia D; Jingsong Z; Lei J; Hairong D; Jun W; Hang X; Weixian C
Cell Biochem Biophys; 2011 Jan; 59(1):39-47. PubMed ID: 20711684
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.
Favier B; Alam A; Barron P; Bonnin J; Laboudie P; Fons P; Mandron M; Herault JP; Neufeld G; Savi P; Herbert JM; Bono F
Blood; 2006 Aug; 108(4):1243-50. PubMed ID: 16621967
[TBL] [Abstract][Full Text] [Related]
9. Effects of semaphorin 3A on retinal pigment epithelial cell activity.
Bai Y; Yu W; Han N; Yang F; Sun Y; Zhang L; Zhao M; Huang L; Zhou A; Wang F; Li X
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6628-38. PubMed ID: 24045994
[TBL] [Abstract][Full Text] [Related]
10. Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice.
Huang C; Wang Y; Huang JH; Liu W
BMC Pharmacol Toxicol; 2017 Jul; 18(1):55. PubMed ID: 28683823
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells.
Ochsenbein AM; Karaman S; Proulx ST; Berchtold M; Jurisic G; Stoeckli ET; Detmar M
Development; 2016 Feb; 143(4):589-94. PubMed ID: 26884395
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.
Gu C; Limberg BJ; Whitaker GB; Perman B; Leahy DJ; Rosenbaum JS; Ginty DD; Kolodkin AL
J Biol Chem; 2002 May; 277(20):18069-76. PubMed ID: 11886873
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
14. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
15. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.
Kigel B; Rabinowicz N; Varshavsky A; Kessler O; Neufeld G
Blood; 2011 Oct; 118(15):4285-96. PubMed ID: 21832283
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.
Acevedo LM; Barillas S; Weis SM; Göthert JR; Cheresh DA
Blood; 2008 Mar; 111(5):2674-80. PubMed ID: 18180379
[TBL] [Abstract][Full Text] [Related]
17. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
Barresi V; Tuccari G
Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.
Coma S; Shimizu A; Klagsbrun M
Cell Adh Migr; 2011; 5(3):266-75. PubMed ID: 21610314
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferases.
Koropouli E; Wang Q; Mejías R; Hand R; Wang T; Ginty DD; Kolodkin AL
Elife; 2023 Apr; 12():. PubMed ID: 37010951
[TBL] [Abstract][Full Text] [Related]
20. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
